SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-22-018053
Filing Date
2022-07-28
Accepted
2022-07-28 21:23:57
Documents
1
Period of Report
2022-07-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 7376
  Complete submission text file 0001437749-22-018053.txt   9721
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Issuer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 16TH FLOOR, YEOKSAM I-TOWER B/D 326, TEHERAN-RO, GANGNAM-GU SEOUL M5 00000
Business Address 16TH FLOOR, YEOKSAM I-TOWER B/D 326, TEHERAN-RO, GANGNAM-GU SEOUL M5 00000 82-2-501-3714
E&Investment, Inc. (Reporting) CIK: 0001796144 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37809 | Film No.: 221116959

Mailing Address 16TH FLOOR, YEOKSAM I-TOWER, 326 TEHERAN-RO, GANGNAM-GU SEOUL M5 06211
Business Address 16TH FLOOR, YEOKSAM I-TOWER, 326 TEHERAN-RO, GANGNAM-GU SEOUL M5 06211 82-2-501-3714
E&Healthcare Investment Fund II (Reporting) CIK: 0001799534 (see all company filings)

State of Incorp.: M5 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37809 | Film No.: 221116958